123 related articles for article (PubMed ID: 16302076)
1. Assessment of staging, prognosis and mortality of colorectal cancer by tumor markers: receptor erbB-2 and cadherins.
Jesus EC; Matos D; Artigiani R; Waitzberg AF; Goldenberg A; Saad SS
Acta Cir Bras; 2005; 20(6):422-7. PubMed ID: 16302076
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma.
Lustosa SA; Logullo A; Artigiani R; Saad SS; Goldenberg A; Matos D
Acta Cir Bras; 2005; 20(5):353-7. PubMed ID: 16186958
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
Mitselou A; Galani V; Skoufi U; Arvanitis DL; Lampri E; Ioachim E
Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
[TBL] [Abstract][Full Text] [Related]
4. The relationship between the stromal mast cell number, microvessel density, c-erbB-2 staining and survival and prognostic factors in colorectal carcinoma.
Elezoğlu B; Tolunay S
Turk Patoloji Derg; 2012; 28(2):110-8. PubMed ID: 22627628
[TBL] [Abstract][Full Text] [Related]
5. Reduced E-cadherin expression and enlargement of cancer nuclei strongly correlate with hematogenic metastasis in colorectal adenocarcinoma.
Ikeguchi M; Taniguchi T; Makino M; Kaibara N
Scand J Gastroenterol; 2000 Aug; 35(8):839-46. PubMed ID: 10994623
[TBL] [Abstract][Full Text] [Related]
6. Beta-catenin and E-cadherin tissue "content" as prognostic markers in left-side colorectal cancer.
Martinez NP; Kanno DT; Pereira JA; Cardinalli IA; Priolli DG
Cancer Biomark; 2010-2011; 8(3):129-35. PubMed ID: 22012768
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the immunohistochemical expressions of MMP-1, MMP-7 and VEGF and prognostic factors in colorectal adenocarcinoma.
Gomes EG; Jucá MJ; de Menezes HL; Nunes BL; Costa H; Lima Fde O; Matos D
Acta Cir Bras; 2009; 24(4):303-10. PubMed ID: 19705030
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.
Choi YS; Shim YM; Kim SH; Son DS; Lee HS; Kim GY; Han J; Kim J
Eur J Cardiothorac Surg; 2003 Sep; 24(3):441-9. PubMed ID: 12965318
[TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of TS, p53, COX2, EGFR, MSH6 and MLH1 biomarkers and its correlation with degree of differentiation, tumor staging and prognostic factors in colorectal adenocarcinoma: a retrospective longitudinal study.
Batista WR; Santos G; Vital FMR; Matos D
Sao Paulo Med J; 2019 May; 137(1):33-38. PubMed ID: 31116268
[TBL] [Abstract][Full Text] [Related]
10. Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer.
Yun JA; Kim SH; Hong HK; Yun SH; Kim HC; Chun HK; Cho YB; Lee WY
Oncology; 2014; 86(5-6):318-28. PubMed ID: 24924873
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of c-erbB-2 protein in colorectal cancer and the correlation with patient survival.
Osako T; Miyahara M; Uchino S; Inomata M; Kitano S; Kobayashi M
Oncology; 1998; 55(6):548-55. PubMed ID: 9778622
[TBL] [Abstract][Full Text] [Related]
12. c-erbB-2 oncoprotein in relation to DNA ploidy and prognosis in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Stål O; Zhang H; Nordenskjöld B
APMIS; 1995 Apr; 103(4):309-15. PubMed ID: 7612263
[TBL] [Abstract][Full Text] [Related]
13. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
14. Expression of protein S100A4 is a predictor of recurrence in colorectal cancer.
Kwak JM; Lee HJ; Kim SH; Kim HK; Mok YJ; Park YT; Choi JS; Moon HY
World J Gastroenterol; 2010 Aug; 16(31):3897-904. PubMed ID: 20712050
[TBL] [Abstract][Full Text] [Related]
15. Negative/low HER2 expression alone or combined with E-cadherin positivity is predictive of better prognosis in patients with breast carcinoma.
Karray-Chouayekh S; Trifa F; Khabir A; Sellami-Boudawara T; Frikha M; Gargouri A; Mokdad-Gargouri R
Histol Histopathol; 2012 Mar; 27(3):377-85. PubMed ID: 22237715
[TBL] [Abstract][Full Text] [Related]
16. [Association of peripheral nerve invasion with clinicopathological factors and prognosis of colorectal cancer].
Han D; Wei Y; Wang X; Wang G; Chen Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):62-66. PubMed ID: 28105622
[TBL] [Abstract][Full Text] [Related]
17. C-erbB-2 oncoprotein content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance.
Vizoso F; Villar C; Rodríguez JC; Raigoso P; García-Muñiz JL; Allende MT; García-Moran M
Int J Surg Investig; 2000; 1(6):483-93. PubMed ID: 11729856
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of serum soluble E-cadherin in colorectal carcinoma.
Okugawa Y; Toiyama Y; Inoue Y; Iwata T; Fujikawa H; Saigusa S; Konishi N; Tanaka K; Uchida K; Kusunoki M
J Surg Res; 2012 Jun; 175(2):e67-73. PubMed ID: 22277332
[TBL] [Abstract][Full Text] [Related]
19. ADAM 10 is associated with gastric cancer progression and prognosis of patients.
Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ
J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]